Recreational marijuana is now legal in California. On January 1st the law went into effect with over 90 dispensaries licensed to sell weed. Greg Zeman, Associate Editor at Cannabis Now, joins Cheddar to discuss the milestone and what's next for the industry.
Zeman breaks down what is believed to be the very first purchase of the now-legal substance in California. The cannabis market is expected to generate at least $1 billion a year in tax revenue for the golden state. He talks about how the state will allocate the money in terms of cannabis education, safety, and boosting other areas of the community such as fire departments.
Plus, how will this impact the medical marijuana industry. Zeman predicts that market will still exist. Many cities in California still don't have a recreational license, so people will still need to rely on their medical marijuana cards to purchase the drug.
Senior Economist at Morning Consult Kayla Bruun shares thoughts on what to expect from the Fed's January meeting and where monetary policy is headed, as well as how consumers are faring.
Former Medtronic CEO and author of 'True North' Bill George explains the steps Boeing leadership must take to regain client and consumer trust after 737 Max 9 production was stopped.
Amazon blamed "regulatory hurdles" for calling off its proposed acquisition of robot vacuum maker iRobot. Not even a Roomba could clean up the deal's antitrust scrutiny.
To celebrate Flutter Entertainment's debut on the NYSE, FanDuel CEO Amy Howe shares her thoughts on the company's plans for growth, the future of online sportsbetting, and Super Bowl Sunday.
Investopedia's Caleb Silver shares thoughts on the upcoming Fed meeting, why individual investors are still slightly skeptical, and what he's looking for from mega cap tech earnings.
Season's greetings! Tax season, that is. January 29 is the first day you can file your tax return. We walk you through each step — plus a checklist you can download.
The Q-Collar helps protect athletes from impact-related concussions. Now, the U.S. Army is evaluating if the device could help reduce traumatic brain injury cased by blast weapons.
Co-founder and executive chairman of the board at Vaxxinity Lou Reese shares how the company is working to bring vaccines for chronic illnesses like heart disease and Parkinson’s to market with an eye for accessibility.
